BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Q, Chen G, Xu H, Xia G, Zhu M, Zhan H, Zhang B, Dai M, Fan H, Liu X. Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo. Front Pharmacol 2021;12:682541. [PMID: 34149427 DOI: 10.3389/fphar.2021.682541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ling J, Huang Y, Sun Z, Guo X, Chang A, Pan J, Zhuo X. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.996728] [Reference Citation Analysis]
2 Li Y, Li L, Li X, Luo B, Ye Q, Wang H, Yang L, Zhu X, Han L, Zhang R, Tian H, Wang P. A mechanistic review of chinese medicine polyphenols on bone formation and resorption. Front Pharmacol 2022;13:1017538. [DOI: 10.3389/fphar.2022.1017538] [Reference Citation Analysis]
3 Lin X, Xu F, Zhang K, Qiu W, Zhang H, Hao Q, Li M, Deng X, Tian Y, Chen Z, Qian A. Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis. Front Cell Dev Biol 2022;10:796227. [DOI: 10.3389/fcell.2022.796227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]